• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PERFUSION SYSTEMS FUSION HOLLOW FIBER OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PERFUSION SYSTEMS FUSION HOLLOW FIBER OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number BB811
Device Problem Increase in Pressure (1491)
Patient Problems Death (1802); Hypoxia (1918); Brain Injury (2219)
Event Date 05/06/2020
Event Type  Death  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information that during a planned heart operation (cabg), the customer reported high pressure during use of the perfusion pack's oxygenator.Hlm primed med 1100 ml ringer, 100 ml mannitol, 10 ml mannitol, 10 ml cyclekapron, 10000ie heparin.Standard prime.Act measure 550 before ecc start.Start of ecc med full flow of 5.2 l/min of normal pre and post membrane pressure.Around 5 to 10 minutes after ecc start the pressure pre membrane rises to higher than 500 mmhg, post membrane normal pressure.Added 500 ml ringer to the heart lung machine in hope of reducing the pre membrane pressure.But pressure is not dropping.The surgeon changed out the cannula without any effect on the high pressure.The surgeon and perfusionist then decided to change out the oxygenator on beating heart, there is no x-clamp placed.Perfusion stopped, oxygenator changed, perfusion started again after approximately 4 minutes.Normalized pressure before the oxygenator at 270/140 mmhg.Perfusion time 109 minutes.Patient is going to intensive care as usual.It was reported that the patient never woke up post op.
 
Manufacturer Narrative
Additional information received reported that the patient sustained severe ischemic brain damage, which in all likelihood is a consequence of the above event.As a result of the severe brain injury active treatment was discontinued, and the patient went died.Other anamesis: in the past essentially well, with a possible unrecognized hypertension.Missed stemi as a prelude to the above intervention.Turns out to have a 3- vessel coronary artery disease.No significant valve pathology.Moderate reduced pump function equivalent to left heart chamber.Device evaluation summary: visual analysis: visual inspection shows no outward signs of physical damage or abnormalities.Device was returned with evidence of blood staining in the fiber bundle.The device was cleaned using a renalin solution.Performance analysis: pressure integrity testing shows no internal or external leaks when run at 3 lpm with 23 psi, (1189 mmhg) of back pressure for 10 minutes.Testing was conducted at a 1:1 ratio (7lpm blood / gas flows) the results are as follows: 206 mmhg blood side pressure drop conclusion: reason for return was undetermined.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FUSION HOLLOW FIBER OXYGENATOR
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
PERFUSION SYSTEMS
7611 northland dr
brooklyn park MN 55428
MDR Report Key10082765
MDR Text Key195412083
Report Number2184009-2020-00026
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
PMA/PMN Number
K172626
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 07/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/22/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator No Information
Device Expiration Date01/31/2022
Device Model NumberBB811
Device Catalogue NumberBB811
Device Lot Number13328942
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/05/2020
Date Manufacturer Received06/11/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death; Hospitalization; Required Intervention;
Patient Age69 YR
Patient Weight93
-
-